PI
LFCR icon

Putnam Investments’s Lifecore Biomedical LFCR Stock Holding History

Putnam Investments’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-286,593
Closed -$3.51M – 1502
2014
Q3 		$3.51M Buy
286,593
+3,937
+1% +$49.1K 0.01% 882
2014
Q2 		$3.53M Buy
282,656
+124,246
+78% +$1.46M 0.01% 890
2014
Q1 		$1.77M Sell
158,410
-8,051
-5% -$88.3K ﹤0.01% 1073
2013
Q4 		$2.02M Sell
166,461
-2,449
-1% -$29.2K ﹤0.01% 1051
2013
Q3 		$2.06M Sell
168,910
-14,923
-8% -$208K 0.01% 1059
2013
Q2 		$2.43M Buy
+183,833
New +$2.54M 0.01% 983

Other funds holding LFCR

WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GC
Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
KG
Killen Group Berwyn, Pennsylvania $866M AUM 0.25% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Putnam Investments's LFCR Position: Q4 2014 in Review

Putnam Investments sold out of Lifecore Biomedical (LFCR) in Q4 2014, closing a stake of 286,593 shares — an estimated $3.51M sold.

Putnam Investments first reported a position in LFCR in Q2 2013 and held it in 6 quarters. The position peaked at $3.53M in Q2 2014. 109 funds tracked by Wall St. Rank hold LFCR as of Q4 2014.

  • Putnam Investments reported no remaining Lifecore Biomedical position as of Q4 2014 after selling out during the quarter.
  • Putnam Investments sold 286,593 Lifecore Biomedical shares in Q4 2014, an estimated $3.51M.
  • Putnam Investments first reported a position in Lifecore Biomedical in Q2 2013 and held it in 6 quarters.
  • Putnam Investments's Lifecore Biomedical position peaked at $3.53M in Q2 2014.
  • 109 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q4 2014.

Based on Putnam Investments's 13F filing for Q4 2014, filed 17 Feb 2015.